Drug intelligence / Profile preview

Nuolitong

Development stage
Unknown
Lead developer
Beijing Plantai Pharmaceutical Technology Development
Modality
Small Molecules
Administration
Oral
01

Overview

Nuolitong is a Traditional Chinese Medicine (TCM) granule formulation developed by Beijing Plantai Pharmaceutical Technology Development Co., Ltd. specifically for the treatment of tension-type headaches. The formulation is designed to promote blood circulation and resolve blood stasis, addressing the underlying 'stasis' believed to cause pain in TCM theory. Its primary botanical ingredients include *Ligusticum chuanxiong* and *Curcuma longa*. Pharmacologically, components like tetramethylpyrazine from *Ligusticum chuanxiong* are known to exert vasodilatory and anti-inflammatory effects, which contribute to the relief of headache symptoms. Nuolitong has been approved in China for the management of tension-type headaches and is used to reduce the frequency and intensity of headache episodes.

Brand names
Nuolitong
Other names
Nuolitong Granules诺力通颗粒
02

Targets

CaV (Voltage-gated calcium channel protein complex)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Nuolitong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuolitong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call